Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11787846 | EphA2 T-cell epitope agonists and uses therefore | Michael S. Kinch | 2023-10-17 |
| 11723963 | Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response | Hideho Okada | 2023-08-15 |
| 10781240 | EPHA2 t-cell epitope agonists and uses therefore | Michael S. Kinch | 2020-09-22 |
| 10434155 | Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response | Hideho Okada | 2019-10-08 |
| 10131699 | EphA2 T-cell epitope agonists and uses therefore | Michael S. Kinch | 2018-11-20 |
| 9937250 | Immunogenic tumor associated stromal cell antigen peptides and methods of their use | Anamika Bose, Jennifer Lynn Taylor, Xi Zhao, Devin B. Lowe | 2018-04-10 |
| 9675642 | Engineered dendritic cells and uses for the treatment of cancer | J. Mark Braughler, Prasanna Kumar, Hideho Okada | 2017-06-13 |
| 9359402 | EphA2 T-cell epitope agonists and uses therefore | Michael S. Kinch | 2016-06-07 |
| 9345770 | Immunogenic tumor associated stromal cell antigen peptides and methods of their use | Anamika Bose, Jennifer Lynn Taylor, Xi Zhao, Devin B. Lowe | 2016-05-24 |
| 8859488 | Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response | Hideho Okada | 2014-10-14 |
| 8574584 | EphA2 T cell epitopes and uses therefor | Michael S. Klnch | 2013-11-05 |
| 8114407 | EphA2 T-cell epitopes and uses therefor | Michael S. Kinch | 2012-02-14 |
| 7612162 | Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response | Hideho Okada, Junichi Eguchi, Hidemitsu Sato | 2009-11-03 |
| 7297337 | EphA2 T-cell epitopes and uses therefor | Michael S. Kinch | 2007-11-20 |
| 6077519 | Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients | Michael T. Lotze | 2000-06-20 |
| 5989565 | Elution and identification of T cell epitopes from viable cells | Michael T. Lotze | 1999-11-23 |